State of Alaska Department of Revenue’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57K Hold
10,067
﹤0.01% 1897
2026
Q1
$63K Buy
10,067
+5,000
+99% +$46.4K ﹤0.01% 1864
2025
Q4
$62K Buy
+5,067
New +$82.8K ﹤0.01% 1874
2023
Q1
Sell
-11,945
Closed -$200K 1633
2022
Q4
$200K Sell
11,945
-533
-4% -$9.22K ﹤0.01% 1596
2022
Q3
$184K Sell
12,478
-1,247
-9% -$24.6K ﹤0.01% 1598
2022
Q2
$375K Buy
13,725
+1,360
+11% +$40.3K ﹤0.01% 1467
2022
Q1
$466K Sell
12,365
-220
-2% -$9.74K ﹤0.01% 1420
2021
Q4
$781K Buy
+12,585
New +$954K 0.01% 1222

Other funds holding OPRX

State of Alaska Department of Revenue's OPRX Position: Q2 2026 in Review

State of Alaska Department of Revenue held its OptimizeRx (OPRX) position steady in Q2 2026 at 10,067 shares worth $57K. The position accounts for ﹤0.01% of the portfolio, ranked #1897.

State of Alaska Department of Revenue first reported a position in OPRX in Q4 2021 and has held it in 8 quarters since. The position peaked at $781K in Q4 2021. 55 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

  • State of Alaska Department of Revenue held 10,067 shares of OptimizeRx worth $57K as of Q2 2026.
  • State of Alaska Department of Revenue left its OptimizeRx share count unchanged in Q2 2026.
  • OptimizeRx made up ﹤0.01% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #1897 holding.
  • State of Alaska Department of Revenue first reported a position in OptimizeRx in Q4 2021 and has held it in 8 quarters since.
  • State of Alaska Department of Revenue's OptimizeRx position peaked at $781K in Q4 2021.
  • 55 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.